Dr. Katherine A. Coerver, MD

Dr. Coerver practices at Ridge View Endoscopy Center - HOPD in Lone Tree, Colorado.

Dr. Coerver's NPI, 1831161157, was assigned on February 2, 2006. Dr. Coerver graduated from Baylor College Of Medicine in 1998. Dr. Coerver holds Colorado license DR0055149.

Dr. Coerver's primary practice is Ridge View Endoscopy Center - HOPD, at 10103 Ridgegate Pkwy, Lone Tree, CO 80124.

Dr. Coerver's primary practice is Ridge View Endoscopy Center - HOPD in Lone Tree, Colorado. Dr. Coerver is also affiliated with AdventHealth Littleton. The medical group on file is Rocky Mountain Neurology. Dmand AI also links Dr. Coerver to 3 more hospitals, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Coerver practices, 7 sites in all. Vendor and product names are available with a free account.

Behavioral neurology and neuropsychiatry is Dr. Coerver's primary specialty in the NPI Registry, under taxonomy code 2084B0040X. Dr. Coerver is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Coerver's licenses on file in 4 states: Colorado, District of Columbia, Maryland and Texas.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, hereditary polyneuropathy, lower back pain and migraine and chronic headache among the conditions Dr. Coerver treats.

CMS data shows 1,124 Medicare services from Dr. Coerver across 13 procedure codes in 2024, for 373 Medicare patients. Medicare paid $134,529 for them. Every service was in an office.

CMS counts 373 Medicare patients who saw Dr. Coerver in 2024. The largest group is 75 to 84, with 167 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Coerver's median patient age at 72, with 62% women.

In 2024, Dr. Coerver wrote 1,661 Medicare Part D claims for 327 patients. 97% of them were for generic drugs. CMS names the drug for 1,463 of them, across 23 drugs with 11 or more claims each, at $41,937 in total drug cost. In 2023, CMS named 1,513 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Coerver for performance year 2024, reported individually. Dr. Coerver accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Coerver, published from 2022 to 2023. The most frequent topics are Antibodies, Monoclonal, Inhibins and Activin Receptors. Dr. Coerver has published most often in Mol Endocrinol. Dr. Coerver's most frequent co-authors are Martin M. Matzuk, PhD, Melissa Jo Armstrong, MD and Milton Joseph Finegold, MD.

CMS Open Payments shows 1,248 general payments to Dr. Coerver from 70 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Eisai Inc. paid the most, $21,114.

Dmand AI lists 2 awards for Dr. Coerver, most recently CMS Stage 1 EHR in 2013.

Dr. Coerver graduated from Baylor College Of Medicine in 1998. Dr. Coerver is a member of AAN.

Dr. Coerver is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.